lifestyle.entreprenerd.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Cantargia
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
April 27, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
April 17, 2026
Cantargia Publishes Annual Report 2025
April 17, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
April 17, 2026
New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference
March 18, 2026